India's Biotech Manufacturing Leap: Talent Pipeline.
Bio-ManufacturingBiotech IndiaLife Sciences JobsManufacturing InnovationPharma Talent
The report explores the significant growth and global positioning of India's biotech manufacturing sector. It outlines how India has expanded its biotech workforce and infrastructure, detailing key policy initiatives like BioE3 and the PLI scheme. The document highlights the demand for skilled professionals across biopharma, biosimilars, and advanced therapies, projecting an ambitious growth trajectory for the bioeconomy. Despite challenges such as talent retention and regulatory hurdles, strategic recommendations are provided to sustain India's competitive edge and achieve projected industry targets by 2030.
Rakshit Badyal, Ghost Research
December 2025
Perspective.
PurposeTo analyze and forecast India's biotech manufacturing growth and talent needs.
AudienceIndustry leaders, policymakers, educators, and researchers in biotech.
Special EmphasisInnovation, policy frameworks, sustainability.
53Pages of Deep Analysis
187Curated Credible Sources
3Proprietary AI Visuals
9Data Analysis Tables
$495
Rakshit Badyal
1+ Years of Experience
Sectors & Industries
IndustrialsInformation Technology
Functions & Expertise
Market Intelligence
Have questions? Our Research Desk is here to help
Top Insights.
India's bioeconomy is projected to reach $300 billion by 2030.Biotech workforce expected to grow from 285,000 in 2025 to 425,000 by 2030.Key policy initiatives include BioE3 and the PLI scheme.Talent challenges include retention and regulatory delays.Strategic recommendations focus on curriculum modernization and public-private collaboration.Key Questions Answered.
53Pages of Deep Analysis
3Proprietary AI Visuals
187Curated Credible Sources
9Data Analysis Tables
Summary.
